MedPath

Andromeda Biotech Ltd.

🇮🇱Israel
Ownership
Private, Subsidiary
Established
2007-01-01
Employees
-
Market Cap
-
Website

Clinical Trials

20

Active:16
Completed:3

Trial Phases

2 Phases

Phase 1:2
Phase 3:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 3
4 (66.7%)
Phase 1
2 (33.3%)

Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®

Phase 3
Terminated
Conditions
Type 1 Diabetes
Interventions
First Posted Date
2013-07-12
Last Posted Date
2016-05-26
Lead Sponsor
Andromeda Biotech Ltd.
Target Recruit Count
38
Registration Number
NCT01898286
Locations
🇺🇸

Atlanta Diabetes associates, Atlanta, Georgia, United States

🇺🇸

Henry Ford Medical Centers - New Center One, Detroit, Michigan, United States

🇺🇸

Mountain Diabetes and Endocrine Center, Asheville, North Carolina, United States

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Phase 3
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
Drug: Placebo
First Posted Date
2010-04-14
Last Posted Date
2016-05-26
Lead Sponsor
Andromeda Biotech Ltd.
Target Recruit Count
475
Registration Number
NCT01103284
Locations
🇺🇸

Sutter Gold Medical Foundation, Modesto, California, United States

🇺🇸

San Diego Clinical Trials, San Diego, California, United States

🇺🇸

University of Colorado Hospital - Anschutz Outpatient Pavilion, Aurora, Colorado, United States

and more 69 locations

Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes

Phase 3
Completed
Conditions
Type 1 Diabetes
Interventions
First Posted Date
2008-03-26
Last Posted Date
2013-07-11
Lead Sponsor
Andromeda Biotech Ltd.
Target Recruit Count
43
Registration Number
NCT00644501
Locations
🇮🇱

Wolfson Medical Centre, Holon, Israel

🇮🇱

Diabetic Unit, Hadassah Medical Center, Jerusalem, Israel

🇮🇱

Schneider Children's Medical Centre, Petach Tikva, Israel

Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients

Phase 3
Completed
Conditions
Type 1 Diabetes
Interventions
Drug: Placebo
First Posted Date
2008-02-14
Last Posted Date
2016-06-06
Lead Sponsor
Andromeda Biotech Ltd.
Target Recruit Count
457
Registration Number
NCT00615264
Locations
🇦🇹

Rudolfstiftung Hospital, Vienna, Austria

🇨🇿

Faculty Hospital, Olomouc, Czech Republic

🇨🇿

Faculty hospital Motol., Prague, Czech Republic

and more 31 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath